| pubmed-article:7676485 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:7676485 | lifeskim:mentions | umls-concept:C0001554 | lld:lifeskim |
| pubmed-article:7676485 | lifeskim:mentions | umls-concept:C0034693 | lld:lifeskim |
| pubmed-article:7676485 | lifeskim:mentions | umls-concept:C0021758 | lld:lifeskim |
| pubmed-article:7676485 | lifeskim:mentions | umls-concept:C0018787 | lld:lifeskim |
| pubmed-article:7676485 | lifeskim:mentions | umls-concept:C0450127 | lld:lifeskim |
| pubmed-article:7676485 | lifeskim:mentions | umls-concept:C0010592 | lld:lifeskim |
| pubmed-article:7676485 | lifeskim:mentions | umls-concept:C0038952 | lld:lifeskim |
| pubmed-article:7676485 | lifeskim:mentions | umls-concept:C1879316 | lld:lifeskim |
| pubmed-article:7676485 | lifeskim:mentions | umls-concept:C0332293 | lld:lifeskim |
| pubmed-article:7676485 | pubmed:issue | 5 | lld:pubmed |
| pubmed-article:7676485 | pubmed:dateCreated | 1995-10-19 | lld:pubmed |
| pubmed-article:7676485 | pubmed:abstractText | It has been hypothesized that immunoregulating cytokines produced by intragraft Th-2 cells may be important for prolonged allograft survival. ACI hearts transplanted into untreated Lewis rat recipients survived for 6.2 days, but they survived for 72.1 days in recipients treated with a donor-specific transfusion and low dose CsA for 14 days. In donor-specific transfusion/CsA-treated animals, intragraft infusion of IL-10 via a 14-day osmotic minipump had no effect on graft survival (75.6 days), but intragraft infusion of IL-4 prolonged graft survival to 149.2 days (P < 0.01). While the actual mechanism of this effect is unclear, it suggests that IL-4 may be important in the development of long-term graft survival. | lld:pubmed |
| pubmed-article:7676485 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7676485 | pubmed:language | eng | lld:pubmed |
| pubmed-article:7676485 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7676485 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:7676485 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7676485 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7676485 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7676485 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:7676485 | pubmed:month | Sep | lld:pubmed |
| pubmed-article:7676485 | pubmed:issn | 0041-1337 | lld:pubmed |
| pubmed-article:7676485 | pubmed:author | pubmed-author:AlexanderJ... | lld:pubmed |
| pubmed-article:7676485 | pubmed:author | pubmed-author:NakaSS | lld:pubmed |
| pubmed-article:7676485 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:7676485 | pubmed:day | 15 | lld:pubmed |
| pubmed-article:7676485 | pubmed:volume | 60 | lld:pubmed |
| pubmed-article:7676485 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:7676485 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:7676485 | pubmed:pagination | 405-6 | lld:pubmed |
| pubmed-article:7676485 | pubmed:dateRevised | 2007-11-14 | lld:pubmed |
| pubmed-article:7676485 | pubmed:meshHeading | pubmed-meshheading:7676485-... | lld:pubmed |
| pubmed-article:7676485 | pubmed:meshHeading | pubmed-meshheading:7676485-... | lld:pubmed |
| pubmed-article:7676485 | pubmed:meshHeading | pubmed-meshheading:7676485-... | lld:pubmed |
| pubmed-article:7676485 | pubmed:meshHeading | pubmed-meshheading:7676485-... | lld:pubmed |
| pubmed-article:7676485 | pubmed:meshHeading | pubmed-meshheading:7676485-... | lld:pubmed |
| pubmed-article:7676485 | pubmed:meshHeading | pubmed-meshheading:7676485-... | lld:pubmed |
| pubmed-article:7676485 | pubmed:meshHeading | pubmed-meshheading:7676485-... | lld:pubmed |
| pubmed-article:7676485 | pubmed:meshHeading | pubmed-meshheading:7676485-... | lld:pubmed |
| pubmed-article:7676485 | pubmed:meshHeading | pubmed-meshheading:7676485-... | lld:pubmed |
| pubmed-article:7676485 | pubmed:meshHeading | pubmed-meshheading:7676485-... | lld:pubmed |
| pubmed-article:7676485 | pubmed:meshHeading | pubmed-meshheading:7676485-... | lld:pubmed |
| pubmed-article:7676485 | pubmed:meshHeading | pubmed-meshheading:7676485-... | lld:pubmed |
| pubmed-article:7676485 | pubmed:year | 1995 | lld:pubmed |
| pubmed-article:7676485 | pubmed:articleTitle | Administration of intragraft interleukin-4 prolongs cardiac allograft survival in rats treated with donor-specific transfusion/cyclosporine. | lld:pubmed |
| pubmed-article:7676485 | pubmed:affiliation | Department of Surgery, University of Cincinnati Medical Center, Ohio 45267-0558, USA. | lld:pubmed |
| pubmed-article:7676485 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:7676485 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| pubmed-article:7676485 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:7676485 | lld:pubmed |
